Syra Health Corp (NASDAQ:SYRA) has a beta value of 4.26 and has seen 6.34 million shares traded in the last trading session. The company, currently valued at $5.22M, closed the last trade at $0.43 per share which meant it gained $0.02 on the day or 4.88% during that session. The SYRA stock price is -544.19% off its 52-week high price of $2.77 and 20.93% above the 52-week low of $0.34.

Syra Health Corp (NASDAQ:SYRA) trade information

Sporting 4.88% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SYRA stock price touched $0.43 or saw a rise of 8.51%. Year-to-date, Syra Health Corp shares have moved 4.39%, while the 5-day performance has seen it change 7.58%. Over the past 30 days, the shares of Syra Health Corp (NASDAQ:SYRA) have changed -14.02%.

Syra Health Corp (SYRA) estimates and forecasts

The company’s shares have lost -68.15% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 44.83%.

1 analysts offering their estimates for the company have set an average revenue estimate of 2.01M for the current quarter.

SYRA Dividends

Syra Health Corp is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 0.30% shares in the company for having 34.25 shares of worth $14726.0 while later fund manager owns 21.45 shares of worth $9225.0 as of Nov 30, 2024 , which makes it owner of about 0.19% of company’s outstanding stock.